These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 34259934

  • 1. Computational study on novel natural inhibitors targeting BCL2.
    Lv X, Jiang Y, Wang X, Xie H, Dou G, Wang J, Yang W, Wang H, Li Z, Zhang X, Chen Z.
    Med Oncol; 2021 Jul 14; 38(8):94. PubMed ID: 34259934
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effective natural inhibitors targeting poly ADP-ribose polymerase by computational study.
    Zhong S, Wu B, Yang W, Ge J, Zhang X, Chen Z, Duan H, He Z, Liu Y, Wang H, Jiang Y, Zhang Z, Wang X, Li W, Liu N, Guo X, Mou Y.
    Aging (Albany NY); 2021 Jan 23; 13(2):1898-1912. PubMed ID: 33486472
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Computational study of novel natural inhibitors targeting aminopeptidase N(CD13).
    Ge J, Wang Z, Cheng Y, Ren J, Wu B, Li W, Wang X, Su X, Liu Z.
    Aging (Albany NY); 2020 May 09; 12(9):8523-8535. PubMed ID: 32388498
    [Abstract] [Full Text] [Related]

  • 9. Novel natural inhibitors targeting KRAS G12C by computational study.
    Jiang Y, Chen W, Wang X, Zhou B, Xie H, Hou Y, Guo Z, Yu B, Zhong S, Su X.
    Anticancer Drugs; 2022 Oct 01; 33(9):779-788. PubMed ID: 35980001
    [Abstract] [Full Text] [Related]

  • 10. Computational study of effective matrix metalloproteinase 9 (MMP9) targeting natural inhibitors.
    Liu N, Wang X, Wu H, Lv X, Xie H, Guo Z, Wang J, Dou G, Zhang C, Sun M.
    Aging (Albany NY); 2021 Oct 04; 13(19):22867-22882. PubMed ID: 34607974
    [Abstract] [Full Text] [Related]

  • 11. Identification of novel natural inhibitors targeting AKT Serine/Threonine Kinase 1 (AKT1) by computational study.
    Zhong S, Zhang Z, Guo Z, Yang W, Dou G, Lv X, Wang X, Ge J, Wu B, Pan X, Wang H, Mou Y.
    Bioengineered; 2022 May 04; 13(5):12003-12020. PubMed ID: 35603567
    [Abstract] [Full Text] [Related]

  • 12. Novel natural inhibitors targeting B-RAF(V600E) by computational study.
    Wu B, Zhang Z, Dou G, Lv X, Ge J, Wang H, Xie H, Zhu D.
    Bioengineered; 2021 Dec 04; 12(1):2970-2983. PubMed ID: 34252351
    [Abstract] [Full Text] [Related]

  • 13. Virtual Screening of Small Molecules Targeting BCL2 with Machine Learning, Molecular Docking, and MD Simulation.
    Tondar A, Sánchez-Herrero S, Bepari AK, Bahmani A, Calvet Liñán L, Hervás-Marín D.
    Biomolecules; 2024 May 01; 14(5):. PubMed ID: 38785951
    [Abstract] [Full Text] [Related]

  • 14. Selected by bioinformatics and molecular docking analysis, Dhea and 2-14,15-Eg are effective against cholangiocarcinoma.
    Qin L, Kuai J, Yang F, Yang L, Sun P, Zhang L, Li G.
    PLoS One; 2022 May 01; 17(2):e0260180. PubMed ID: 35113866
    [Abstract] [Full Text] [Related]

  • 15. GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner.
    Xia Z, Zhang X, Liu P, Zhang R, Huang Z, Li D, Xiao X, Wu M, Ning N, Zhang Q, Zhang J, Liu M, Jiao B, Ren R.
    Cell Death Dis; 2021 Jan 09; 12(1):54. PubMed ID: 33423045
    [Abstract] [Full Text] [Related]

  • 16. Phytosterols and triterpenes from Morinda lucida Benth (Rubiaceae) as potential inhibitors of anti-apoptotic BCL-XL, BCL-2, and MCL-1: an in-silico study.
    Adewole KE, Ishola AA.
    J Recept Signal Transduct Res; 2019 Feb 09; 39(1):87-97. PubMed ID: 31215288
    [Abstract] [Full Text] [Related]

  • 17. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.
    Dupont T, Yang SN, Patel J, Hatzi K, Malik A, Tam W, Martin P, Leonard J, Melnick A, Cerchietti L.
    Oncotarget; 2016 Jan 19; 7(3):3520-32. PubMed ID: 26657288
    [Abstract] [Full Text] [Related]

  • 18. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
    Shukla R, Shukla H, Sonkar A, Pandey T, Tripathi T.
    J Biomol Struct Dyn; 2018 Jun 19; 36(8):2045-2057. PubMed ID: 28605994
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK).
    Ma L, Li R, Yao Z, Wang B, Liu Y, Liu C, Wang H, Chen S, Sun D.
    Aging (Albany NY); 2022 Oct 25; 14(20):8394-8410. PubMed ID: 36287174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.